Cochrane · systematic review · CD009758
Interventions for the prevention of recurrent erysipelas and cellulitis
Dalal, A, Eskin‐Schwartz, M, Mimouni, D, et al. · Cochrane Database of Systematic Reviews · 2017 · Cochrane Library
SkinAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
6
current version
GRADE rated
5
No studies
1
Included studies
NR
No studies 1 · 16.7%Ungraded 0 · 0%Very low 0 · 0%Low 2 · 33.3%Moderate 3 · 50%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Antibiotic prophylaxis compared to no treatment/placebo for the prevention of recurrent erysipelas and cellulitis
Population: People with recurrent erysipelas or cellulitis
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Recurrence of cellulitis Antibiotic prophylaxis vs no treatment/placebo | RR 0.31 [0.13, 0.72] | 5 studies · 513 participants | Moderate Downgraded: imprecision |
Incidence rate of cellulitis Antibiotic prophylaxis vs no treatment/placebo | RR 0.44 [0.22, 0.89] | 4 studies · 473 participants | Moderate Downgraded: imprecision |
Time to next episode of cellulitis Antibiotic prophylaxis vs no treatment/placebo | HR 0.51 [0.34, 0.78] | 3 studies · 437 participants | Moderate Downgraded: imprecision |
Hospitalisation Antibiotic prophylaxis vs no treatment/placebo | RR 0.77 [0.37, 1.57] | 3 studies · 429 participants | Low Downgraded: risk of bias, imprecision |
Any adverse reactions Antibiotic prophylaxis vs no treatment/placebo | RR 0.87 [0.58, 1.3] | 4 studies · 469 participants | Low Downgraded: risk of bias, imprecision |
Quality of life Antibiotic prophylaxis vs no treatment/placebo | no estimate extracted | NR | No studies |